Bio-Rad Laboratories Inc (BIO)
Return on assets (ROA)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | -1,844,200 | -637,324 | -3,627,540 | 4,254,260 | 3,814,230 |
Total assets | US$ in thousands | 9,364,100 | 12,299,100 | 13,501,700 | 17,775,800 | 12,972,600 |
ROA | -19.69% | -5.18% | -26.87% | 23.93% | 29.40% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $-1,844,200K ÷ $9,364,100K
= -19.69%
Bio-Rad Laboratories Inc's Return on Assets (ROA) reflects its ability to generate profits relative to its total assets. The trend in ROA over the years indicates fluctuations in the company's efficiency in utilizing its assets to generate earnings.
In 2020, Bio-Rad Laboratories Inc achieved a robust ROA of 29.40%, showcasing effective management of assets to generate profits. However, in 2021, the ROA decreased to 23.93%, suggesting a slight decline in asset efficiency.
The following years saw a significant downturn in ROA performance. By December 31, 2022, the ROA turned negative to -26.87%, indicating that the company's assets were not effectively contributing to profitability. The declining trend continued in 2023 and 2024 with ROA values of -5.18% and -19.69% respectively, illustrating persistent challenges in asset utilization and profit generation.
Overall, the fluctuating trend in Bio-Rad Laboratories Inc's ROA signals varying levels of asset efficiency and profitability over the years, highlighting the importance of monitoring and addressing factors affecting the company's overall asset management strategies.
Peer comparison
Dec 31, 2024